ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MXCT Maxcyte Inc

365.00
-2.00 (-0.54%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -2.00 -0.54% 365.00 360.00 370.00 365.00 365.00 365.00 1,623 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 41.29M -37.92M -0.3664 -12.42 470.95M
Maxcyte Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker MXCT. The last closing price for Maxcyte was 367p. Over the last year, Maxcyte shares have traded in a share price range of 172.50p to 420.00p.

Maxcyte currently has 103,504,571 shares in issue. The market capitalisation of Maxcyte is £470.95 million. Maxcyte has a price to earnings ratio (PE ratio) of -12.42.

Maxcyte Share Discussion Threads

Showing 301 to 322 of 1500 messages
Chat Pages: Latest  24  23  22  21  20  19  18  17  16  15  14  13  Older
DateSubjectAuthorDiscuss
09/12/2020
16:31
Well the market disagree's with you - the editas share price has doubled in 5 days.

My reference to breakthrough was in terms of PR for maxcyte... as in its a big breakthrough their tech is used by a serious gene editing company as a solution to manufacturing plans...that imo is rns worthy.

nimbo1
07/12/2020
20:32
I don't think the Editas announcement is a breakthrough. It's preclinical data and they haven't yet filed for an IND which would permit them to undertake clinical trials in humans. I think the most important element of the Editas announcement is their comment on manufacturing: "... the Company’s large-scale manufacturing process was shown to be consistent and robust." Earlier this year, Allogene had a slide covering the accomplishments of their ALLO-501 trial and the first bullet point was that they had "ticked the box" on the manufacturing process. There's good potential for one or more registrational Phase 2 trial initiations in 2021 which bring an early 7 figure milestone (once all of the milestones associated with the registrational trial have been earned). A registrational Phase 2 would also result in a faster time to market (since you skip Phase 3). This strategy was pursued by David Chang (Allogene CEO) when he was at Kite.
gsbmba99
07/12/2020
16:47
Thanks nimbo , you're a real sleuth!
assagai
07/12/2020
16:37
maxcyte congratulating their partner editas on their news from the weekend.
nimbo1
07/12/2020
14:47
Ah the trade was cancelled, must have been a case of fat fingers.
acuere
07/12/2020
13:09
Somebody just paid 480p for 1000. That’s a serious premium to the quoted 450.
acuere
07/12/2020
09:29
Despite my best efforts just couldn't stop myself buying another 4k this morning......
assagai
06/12/2020
14:03
thanks ref link tip.

I really think this space is going to be massive and 2021 or perhaps now is when it is taking off...Still early days in this sector.

My current exposure is Maxcyte 10% and Crispr 7%.

Why I don't already own NVTA, PACB etc Im not sure.

nimbo1
06/12/2020
11:08
This CRISPR conference call also may be of interest:


transcript of the call here:


nimbo, you can make a link work by changing the t's in http to capitals (hTTp).

homebrewruss
06/12/2020
10:28
anyone interested in maxcyte or genomics should listen to this presentation from august from Cathy wood for 22 mins. Then look at the share prices of the top stocks in the genomics etf. Crispr, Arcturus, Pacific biosciences, Invitae, Twist, Personalis etc.

Maxcyte is the enabling platform for crispr and Editas along with others (you can see deals struck).

nimbo1
05/12/2020
23:08
I have no idea on carma as I have no insight other than rns's. I'm not concerned, this year or q1 next...what I am bothered about is maxcyte going to nasdaq asap.
nimbo1
05/12/2020
22:41
Thanks for posting that link. My largest position too. Looking forward to the next several years and just hoping that they don’t exit to something way beneath what they could achieve
adamb1978
05/12/2020
22:16
Due you still think the Carma Spinout will happen this year?
assagai
05/12/2020
21:58
I noticed I spelled your name wrong too... issue with typing on a phone...

This news is very significant - this could be the first drug made using maxcyte's platform... still some way off but no wonder maxcyte confident already for next year...there will be increasingly significant milestone payments at some point.

In all seriousness this is a $750mil-$1bil company on nasdaq imo all being well.

nimbo1
05/12/2020
21:41
So sorry, bloody autocorrect!
assagai
05/12/2020
21:33
ha might change my name to that - like it.

it's mine too.

nimbo1
05/12/2020
21:12
Hi nimbo, reckon it will appear down.....but only because of the UT trade on Fridays close.
I won't be buying any more but only because I'm fully loaded!!
It's my biggest holding now.

Thanks Homebrew

assagai
05/12/2020
21:01
Hi assagi, not sure how many know the link or appreciate it but if it opens flat or down on Monday I’ll probably pick up some more :)
nimbo1
05/12/2020
18:38
hxxps://www.globenewswire.com/news-release/2020/12/05/2140152/0/en/CRISPR-Therapeutics-and-Vertex-Present-New-Data-for-Investigational-CRISPR-Cas9-Gene-Editing-Therapy-CTX001-at-American-Society-of-Hematology-Annual-Meeting-and-Exposition-Together.html

Good news for maxcyte

nimbo1
02/12/2020
23:32
Good twitter thread on MXCT
homebrewruss
02/12/2020
09:23
No online quote to buy at the moment.
bamboo2
02/12/2020
09:13
The 'no-reason' breakaway gap at 370-374 is probably going to fill.
This gap was the result of a tip somewhere I think.

It is an area of historical support and will hold imo.
Possible turn shows on the chart 2-3/12/2020

bamboo2
Chat Pages: Latest  24  23  22  21  20  19  18  17  16  15  14  13  Older